Herduo Tablet is used in the treatment of breast cancer. It works by stopping or slowing down the growth of cancer cells. It is either used alone or in combination with some other medicine to cure advanced-stage breast cancer.

Herduo Tablet is used to treat different types of cancer

Uses of Herduo Tablet

Breast cancer

Benefits of Herduo Tablet

In Breast cancer

Herduo Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Herduo Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

Side effects of Herduo Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Herduo

Abdominal pain
Back pain
Breathing problems
Constipation
Cough
Diarrhea
Fatigue
Headache
Hot flashes
Increased bilirubin in the blood
Insomnia (difficulty in sleeping)
Joint pain
Liver damage
Loss of appetite
Mucosal inflammation
Nausea
Pain in extremities
Rash
Stomatitis (Inflammation of the mouth)
Vomiting
Weakness
Weight gain

How to use Herduo Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Herduo Tablet is to be taken empty stomach.

How Herduo Tablet works

Herduo Tablet is an anti-cancer medication. It works against the HER2 (human epidermal growth factor receptor protein) receptors and EGFRs (epidermal growth factor receptor) which are responsible for the over-proliferation of cells. This is how it inhibits the growth of cancerous cells causing downstream signaling pathways.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Herduo Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Herduo Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding

UNSAFE

Herduo Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

UNSAFE

Herduo Tablet may cause side effects which could affect your ability to drive.

Kidney

CAUTION

Herduo Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Herduo Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Herduo Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.

Liver

CAUTION

Herduo Tablet should be used with caution in patients with liver disease. Dose adjustment of Herduo Tablet may be needed. Please consult your doctor.
Limited information is available on the use of this medicine in patients with the severe liver disease.

What if you forget to take Herduo Tablet?

If you miss a dose of Herduo Tablet, consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Herduo Tablet

₹200.0/Tablet

Tykerb 250mg Tablet

Glaxo SmithKline Pharmaceuticals Ltd

₹445/tablet

123% costlier

Neolapa 250mg Tablet

Neon Laboratories Ltd

₹96.67/tablet

52% cheaper

Hertab 250mg Tablet

Hetero Healthcare Limited

₹198.33/tablet

1% cheaper

Libset Tablet

Intas Pharmaceuticals Ltd

₹199.83/tablet

same price

Bretolap Tablet

Alkem Laboratories Ltd

₹199.67/tablet

same price

View all substitutes

Quick tips

It should be taken 1 hour before or 2 hours after the meal, preferably at the same time every day.
Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, confusion, problems with your eyesight, nausea or vomiting.
It may cause serious bleeding problem. Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
Do not take this medicine if you are pregnant, planning to conceive or breastfeeding.

Fact Box

Chemical Class

Quinazolinamines Derivative

Habit Forming

Therapeutic Class

abcde

Action Class

Tyrosine kinase inhibitors

Patient concerns

If any symtom of brest cancer if have whats the cure

Dr. Sanjay Singh Rai

Medical Oncology and Hematology

First is confirmation of breast cancerChance of cure depends on stage of cancer

BREAST CANCER , PET REPORT SAYS INFECTION IN SKELETON.

Dr. Sanjay Singh Rai

Medical Oncology and Hematology

Metastatic breast cancer, send me previous treatment details

Related lab tests

Breast Cancer (CA 15.3/ ER/ PR)

Related ayurvedic ingredients

Olive oil

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1737-38.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 779-80.
Lapatinib ditosylate monohydrate. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2008 [revised 13 Dec. 2018]. [Accessed 23 Jan. 2019] (online) Available from:
Lapatinib. Research Triangle Park, North Carolina: GlaxoSmithKline; 2007 [revised Mar. 2015]. [Accessed 26 Mar. 2019] (online) Available from:
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Lapatinib. [Updated 2019 Jan 7]. [Accessed 18 Feb. 2020] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:

Marketer details

Name: Natco Pharma Ltd

Address: Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.